A Chronic Obstructive Pulmonary Disease Exacerbation Following the Administration of a COVID 19-Booster Vaccine: A Case Report. (Record no. 79)

MARC details
000 -LEADER
fixed length control field 01805nam a22003377a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 221213s20222022 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2000-9666
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.55729/2000-9666.1107 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code jchim-12-05-110 [pii]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code PMC9529658 [pmc]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 36262495
245 ## - TITLE STATEMENT
Title A Chronic Obstructive Pulmonary Disease Exacerbation Following the Administration of a COVID 19-Booster Vaccine: A Case Report.
251 ## - Source
Source Journal of Community Hospital Internal Medicine Perspectives. 12(5):110-113, 2022.
252 ## - Abbreviated Source
Abbreviated source J Community Hosp Intern Med Perspect. 12(5):110-113, 2022.
253 ## - Journal Name
Journal name Journal of community hospital internal medicine perspectives
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2022
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2023
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status epublish
266 ## - Date added to catalog
Date added to catalog 2022-12-13
520 ## - SUMMARY, ETC.
Abstract We present a case of a patient who presented to the emergency department with symptoms suggestive of a chronic obstructive pulmonary disease (COPD) exacerbation one day after receiving the BNT162b2 COVID-19 booster vaccine. Laboratory studies indicated she was in a state of inflammation, but not infection. Other potential triggers, including cardiac and viral etiologies, were ruled out. To our knowledge, this is the first documented case of a COPD exacerbation following the administration of the BNT162b2 COVID-19 vaccine. Copyright © 2022 Greater Baltimore Medical Center.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Franklin Square Medical Center
657 ## - INDEX TERM--FUNCTION
Medline publication type Case Reports
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Paudel, Amrit
Institution Code MFSMC
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Saleh, Nahar
Institution Code MFSMC
790 ## - Authors
All authors Dominah G, Gatenby W, Paudel A, Saleh N
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.55729/2000-9666.1107">https://dx.doi.org/10.55729/2000-9666.1107</a>
Public note https://dx.doi.org/10.55729/2000-9666.1107
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 12/13/2022   36262495 36262495 12/13/2022 12/13/2022 Journal Article

Powered by Koha